Personalizing thyroid cancer care: Are we there yet?

Annals of Surgical Oncology

Volumn 18, Issue 7, 2011, Pages 1819-1820

  Nilubol, Naris ^a   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; HYPOXIA INDUCIBLE FACTOR 1; MICRORNA; MICRORNA 130B; MICRORNA 138; MICRORNA 146B; MICRORNA 155; MICRORNA 221; MICRORNA 222; MICRORNA 34B; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CANCER STAGING; CELL DIFFERENTIATION; CELL MATURATION; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; EDITORIAL; FOLLOW UP; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MARKER GENE; METASTASIS; PATIENT CARE; PERSONALIZED MEDICINE; POSTTRANSCRIPTIONAL GENE SILENCING; PROGNOSIS; PROTO ONCOGENE; REPRODUCIBILITY; RNA TRANSLATION; SCORING SYSTEM; SOMATIC MUTATION; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

HUMANS; INDIVIDUALIZED MEDICINE; THYROID NEOPLASMS;

EID: 80051551263     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1735-y     Document Type: Editorial

References (7)

1. Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol). 2010;22:395-404.
2. Wang Y, Ji M, Wang W, Miao Z, Hou P, Chen X, et al. Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and overexpression of platelet-derived growth factor-B in papillary thyroid cancer. Endocr Relat Cancer. 2008;15:183-90. (Pubitemid 351449738)
3. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol. 2009;27:2977-82.
4. Shibru D, Chung KW, Kebebew E. Recent developments in the clinical application of thyroid cancer biomarkers. Curr Opin Oncol. 2008;20:13-8. (Pubitemid 350190976)
5. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009;27:5848-56.
6. Nardone HC, Ziober AF, LiVolsi VA, Mandel SJ, Baloch ZW, Weber RS, et al. c-Met expression in tall cell variant papillary carcinoma of the thyroid. Cancer. 2003;98:1386-93. (Pubitemid 37151492)
7. Scarpino S, Cancellario d'Alena F, Di Napoli A, Pasquini A, Marzullo A, Ruco LP. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF- 1) in tumour cells in papillary carcinoma of the thyroid. J Pathol. 2004;202:352-8. (Pubitemid 38325245)